Showing results (221-230 of 331) with videos related to
Sort By:
Pageof 34
Journal of Pharmacy Practice|June 30, 2011
The role of the emergency pharmacist in trauma resuscitationThomas R Scarponcini, Christopher J Edwards, Maria I Rudis, et al.Rheumatology and Therapy|November 27, 2020
A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid ArthritisChristopher J Edwards, Ruta Sawant, Vishvas Garg, et al.Journal of Pain & Palliative Care Pharmacotherapy|May 11, 2017
Benefits of Thoracic Epidural Analgesia in Patients Undergoing an Open Posterior Component Separation for Abdominal HerniorrhaphyDaryl S Henshaw, Christopher J Edwards, Austin R Sellers, et al.BMC Musculoskeletal Disorders|April 8, 2020
Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?Tom Nadin, Dinny Wallis, Christopher R Holroyd, et al.Chest|August 22, 2014
Surge capacity logistics: care of the critically ill and injured during pandemics and disasters: CHEST consensus statementSharon Einav, John L Hick, Dan Hanfling, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 27, 2018
Comparison of blood product use and costs with use of 3-factor versus 4-factor prothrombin complex concentrate for off-label indicationsJessica DeAngelo, Daniel H Jarrell, Richard Cosgrove, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 19, 2017
Development of the Critical Care Pharmacotherapy Trials NetworkSeth R Bauer, Prasad E Abraham, Jeffrey F Barletta, et al.Annals of the New York Academy of Sciences|September 24, 2005
Improving predictive modeling in pediatric drug development: pharmacokinetics, pharmacodynamics, and mechanistic modelingWilliam Slikker, John F Young, Richard A Corley, et al.The Journal of Rheumatology. Supplement|September 4, 2012
Pain pharmacotherapy in patients with inflammatory arthritis and concurrent cardiovascular or renal disease: a Cochrane systematic reviewJonathan L Marks, Désirée M van der Heijde, Alexandra N Colebatch, et al.Arthritis and Rheumatism|October 2, 2007
The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritisChristopher J Edwards, Cyrus Cooper, David Fisher, et al.Pageof 34